|
gptkbp:instanceOf
|
gptkb:chemical_compound
benzodiazepine
|
|
gptkbp:ATCCode
|
N05BA13
|
|
gptkbp:CASNumber
|
1088-11-5
|
|
gptkbp:chemicalClass
|
1,4-benzodiazepine
|
|
gptkbp:discoveredBy
|
1960s
|
|
gptkbp:drugClass
|
benzodiazepine
sedative
anticonvulsant
muscle relaxant
|
|
gptkbp:eliminationHalfLife
|
36-200 hours
|
|
gptkbp:has_metabolite
|
gptkb:oxazepam
|
|
gptkbp:has_parent_compound
|
gptkb:diazepam
gptkb:chlordiazepoxide
clorazepate
medazepam
prazepam
|
|
gptkbp:hasInChIKey
|
GBJXUKXGFITWSI-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C15H11ClN2O
|
|
gptkbp:hasSMILES
|
C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=CC(=C3)Cl)=N
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
nordiazepam
|
|
gptkbp:is_controlled_substance
|
yes
|
|
gptkbp:IUPACName
|
7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
239-240 °C
|
|
gptkbp:metabolism
|
gptkb:diazepam
gptkb:chlordiazepoxide
clorazepate
medazepam
prazepam
|
|
gptkbp:molecularWeight
|
270.72 g/mol
|
|
gptkbp:PubChem_CID
|
4537
CHEMBL1077
DB01579
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
confusion
fatigue
drowsiness
ataxia
dependence
|
|
gptkbp:solubility
|
slightly soluble
|
|
gptkbp:synonym
|
demethyldiazepam
desmethyldiazepam
nordazepam
|
|
gptkbp:UNII
|
5WIX9VGK49
|
|
gptkbp:usedFor
|
benzodiazepine
sedative
anticonvulsant
muscle relaxant
|
|
gptkbp:bfsParent
|
gptkb:Chlordiazepoxide
gptkb:chlordiazepoxide
|
|
gptkbp:bfsLayer
|
7
|